Certified Startup
KOLPHA CARE LLP
Sector:
Healthcare
Business Model:
B2C B2B
Industry:
Pharma
Technology:
Biotechnology
About
Incorporation Date
Nov 7, 2025
Incorporation Type
Limited Liability Partnership
Registered State
Kerala
Registered District
Idukki
Registered Address
Kollarmaly House, Rajakumary South P.O., Idukki, Idukki, Kerala
Office State
Kerala
Office District
Idukki
Office Address
Kollarmaly House Rajakumari South
Team
No Photo
KOLLARMALY ETHAPPIRI PAILY
Co-founder
No Photo
AJIX KOLLAMPARAMBIL JOY
Co-founder
Ozagen
Ozagen is a branded semaglutide formulation developed to deliver affordable peptide therapy without compromising quality. Manufactured using HPLC technology, it achieves a minimum 95% peptide purity. Production follows GMP-compliant processes, with APIs sourced from reputable manufacturers, ensuring consistent quality, reliability, accessibility, and value for patients and healthcare providers.
Sector:
Healthcare
Industry:
Pharma
Business Models:
B2C B2B
Technology:
Biotechnology

Overview: Ozagen is a branded semaglutide formulation developed with the vision of making high-quality, cost-effective peptide therapies more accessible. The project focuses on delivering reliable product quality while reducing barriers to access through efficient manufacturing and responsible sourcing.

Product Quality: Ozagen is manufactured using High-Performance Liquid Chromatography (HPLC) technology to achieve a minimum peptide purity of 95%, ensuring consistent product quality and batch reliability. Quality control measures are incorporated throughout production to maintain uniformity, stability, and performance.

Manufacturing Standards: Production is carried out using Good Manufacturing Practice (GMP)-compliant processes with an emphasis on quality assurance, process consistency, and product safety. Active Pharmaceutical Ingredients (APIs) are sourced from established and reputable manufacturers to support dependable manufacturing standards.

Research and Development: In addition to its primary intended application, Ozagen is designed as a platform for continued research into broader therapeutic uses of semaglutide. The project aims to evaluate emerging opportunities through scientific investigation while maintaining a commitment to quality and innovation.

Accessibility and Affordability: Ozagen's mission is to make peptide-based therapies more affordable without compromising manufacturing quality. By optimizing production and sourcing strategies, the project seeks to provide a cost-effective formulation that expands access to advanced peptide technologies for a wider population.

Key Features
Branded semaglutide formulation
Minimum 95% peptide purity verified using HPLC technology
Manufactured through GMP-compliant production processes
APIs sourced from reputable manufacturers
Focus on consistent quality and product reliability
Cost-effective peptide formulation designed to improve accessibility
Commitment to ongoing research into wider therapeutic applications
Built on principles of quality, affordability, and innovation

Ozagen represents a commitment to delivering accessible peptide solutions by combining stringent quality practices, reliable manufacturing, and continuous research to support the evolving needs of healthcare and peptide therapeutics.

All right reserved © 2026 | Kerala Startup Mission
For any Queries / Technical Support drop a mail to admin@startupmission.in